Highlights Roche Holding AG

Equities

ROP

CH1499059983

Pharmaceuticals

End-of-day quote Swiss Exchange Other stock markets 2026-06-05			5-day change	1st Jan Change
327.10 ^CHF	+0.77%		-0.67%	-0.34%

07:32pm	Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial	RE
Jun. 05	Zealand touts promising tolerability data for obesity drug in mid-stage study	RE

Highlights

Jun. 05	Zealand touts promising tolerability data for obesity drug in mid-stage study	RE
Jun. 02	Foundation Medicine Receives Fda Approval for Foundationone Cdx as Companion Diagnostic for Itovebi in Combination with Palbociclib and Fulvestrant	CI
Jun. 02	Roche Receives FDA Acceptance For New Drug Application For Giredestrant In ER-Positive Early-Stage Breast Cancer	CI
Jun. 02	Roche Wins US FDA's Priority Review for Breast Cancer Treatment Giredestrant	MT
Jun. 01	Roche Presents New Data Advancing Its Obesity Portfolio At The American Diabetes Association?s 2026 Scientific Sessions	CI
May. 27	Roche Introduces Certified Algorithm-based Liver Disease Panel	MT
May. 27	Roche Launches the Liver Disease Panel Suite of Certified Algorithms to Support Chronic Liver Disease Management	CI
May. 18	Roche Expands Access to Influenza Drug Xofluza Via License Deal with MPP	MT
May. 18	MPP and Roche sign voluntary licence agreement for baloxavir marboxil	RE
May. 18	Roche, Medicines Patent Pool sign deal to expand access to influenza drug	RE
May. 18	AstraZeneca, Roche Unit to Advance Digital Pathology for Breast, Lung Cancer in Asia	MT
May. 17	Roche's Genentech Wins US Approval for Bladder Cancer Treatment	MT
May. 15	Fda approves Genentech's Tecentriq for adjuvant muscle-invasive bladder cancer with ctDNA-guided treatment	RE
May. 15	FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in some patients	RE
May. 12	Roche Receives CE Mark For Elecsys Ptau217 Blood Test For Alzheimer?S Disease Pathology	CI
May. 12	Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030	DJ
May. 12	Roche receives CE mark for new blood test to detect Alzheimer's pathology	RE
May. 07	Roche Holding AG entered into a definitive merger agreement to acquire PathAI, Inc. for $1.1 billion.	CI
May. 07	Switzerland's Roche agrees to acquire US-based PathAI	RE
May. 07	Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools	DJ
May. 07	Roche Expands With Up to $1 Billion Acquisition of US-based PathAI	MT
May. 07	Roche enters to acquire PathAI for $750 million upfront	RE
Apr. 30	Roche Showcases Ophthalmology Portfolio At Arvo 2026	CI
Apr. 29	Zealand Pharma A/S and Roche to Advance Petrelintide, Amylin Analog, to Phase 3 Trials for Chronic Weight Management	CI
Apr. 23	Roche Holding: An assuring start to the year